Your browser doesn't support javascript.
loading
Combination of cisplatin, epirubicin, and cyclophosphamide (PEC regimen) in advanced or recurrent endometrial cancer: a retrospective clinical study.
Gadducci, A; Romanini, A; Cosio, S; Fanucchi, A; Tanganelli, L; Ciampi, B; Genazzani, A R.
Affiliation
  • Gadducci A; Department of Procreative Medicine, University of Pisa, Italy.
Anticancer Res ; 19(3B): 2253-6, 1999.
Article in En | MEDLINE | ID: mdl-10472339
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Endometrial Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 1999 Document type: Article Affiliation country: Italia Country of publication: Grecia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Endometrial Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 1999 Document type: Article Affiliation country: Italia Country of publication: Grecia